Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Differentiation/involution-inducing agents in development at Maxia for breast cancer

Nov. 25, 2002

Korean researchers select novel HDAC inhibitor for further evaluation as potential cancer therapy

Nov. 25, 2002

MX-7091: a selective MKP-1 inhibitor with potential in anticancer therapy

Nov. 25, 2002

Integrin antagonist demonstrates significant antitumor/antimetastatic activity

Nov. 25, 2002

NeoPharm terminates license agreement with Pharmacia

Nov. 25, 2002

Eximias grants rights for Thymitaq to LG Life Sciences

Nov. 25, 2002

SBIR grant supports development of second-generation angiostatin proteins for cancer

Nov. 25, 2002

Phase I/II clinical findings for MTC-DOX reported at EORTC-NCI-AACR symposium

Nov. 22, 2002

DNA-targeted anticancer agent DRH-417 undergoes preclinical testing

Nov. 22, 2002

Lycobetaine derivatives with improved antitumor activity

Nov. 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...